VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Tenet Healthcare Corporation $THC

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Tenet Healthcare Corporation (NYSE:THCFree Report) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 29,421 shares of the company’s stock, valued at approximately $5,504,000.

Several other institutional investors have also recently modified their holdings of the company. California State Teachers Retirement System grew its position in Tenet Healthcare by 18,362.2% during the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock valued at $3,533,142,000 after acquiring an additional 18,783,432 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Tenet Healthcare by 1.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after buying an additional 119,809 shares during the period. Boston Partners lifted its stake in shares of Tenet Healthcare by 15.7% in the 4th quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after acquiring an additional 494,581 shares during the last quarter. AQR Capital Management LLC grew its position in Tenet Healthcare by 20.3% during the 4th quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock worth $448,419,000 after acquiring an additional 380,116 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after purchasing an additional 157,109 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Barclays raised their target price on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. Guggenheim lifted their price target on shares of Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a report on Tuesday, July 28th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 23rd. Morgan Stanley boosted their price target on shares of Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research report on Monday, July 27th. Finally, Zacks Research upgraded shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $273.00.

Check Out Our Latest Stock Analysis on Tenet Healthcare

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $259.37 on Wednesday. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $283.05. The firm’s 50-day moving average is $241.08 and its 200 day moving average is $211.50. The stock has a market cap of $20.88 billion, a price-to-earnings ratio of 10.00, a PEG ratio of 1.01 and a beta of 1.23. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35.

Tenet Healthcare (NYSE:THCGet Free Report) last released its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. Tenet Healthcare’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 21.04 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Tammy Romo sold 2,500 shares of the firm’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00. Following the sale, the director owned 28,284 shares of the company’s stock, valued at $7,377,315.72. This trade represents a 8.12% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Saumya Sutaria sold 50,000 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $278.71, for a total transaction of $13,935,500.00. Following the transaction, the chief executive officer owned 483,564 shares in the company, valued at approximately $134,774,122.44. This trade represents a 9.37% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 109,189 shares of company stock worth $29,264,109. 0.97% of the stock is owned by corporate insiders.

Tenet Healthcare Company Profile

(Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Further Reading

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THCFree Report).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.